Ketoprofene salt of lysine 0,16% - spray for oropharyngeal cavity 15 ml

Product Description

Spray against inflammation and irritation of the oropharyngeal cavity.

Indications

Ketoprofen Lysine Salt 0.16% Spray for Oral Mucosa is a spray for the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a result of conservative or extractive dental therapy.

Composition

Active ingredient: 100 ml of spray for oral mucosa contain 0.16 g of Ketoprofen lysine salt corresponding to 0.10 g of Ketoprofen.
Excipients: Glycerol 85%, xylitol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, sodium phosphate monobasic, poloxamer, mint flavoring, purified water.

Directions for use and dosage

1-2 sprays up to 3 times a day, directed directly at the affected area.
Each spray delivers approximately 0.2 ml of solution, equivalent to 0.32 mg of active ingredient.

Warnings

The use of topical medications, especially if prolonged, can cause serious side effects. give rise to sensitization phenomena, in which case it is necessary to suspend treatment and adopt appropriate therapeutic measures.
Important information on some excipients: The medicinal product contains para-hydroxybenzoates, which can cause allergic reactions (even delayed).

Interactions

No interaction studies with other medicinal products have been performed.

Contraindications

Ketoprofen lysine salt Zentiva 0.16% oral mucosal spray must not be administered in case of hypersensitivity to the active substance, to other non-steroidal anti-inflammatory drugs (NSAIDs) or to any of the excipients listed, to patients in whom substances with a similar mechanism of action (for example acetylsalicylic acid or other NSAIDs) cause asthma attacks, bronchospasm, acute rhinitis, or cause nasal polyps, urticaria or angioneurotic edema, in case of bronchial asthma. previous history, during pregnancy and breastfeeding.

Side effects

Local side effects following topical administration of ketoprofen lysine salt solution to the oral mucosa are extremely rare and consist of irritative or allergic phenomena (angioneurotic edema), especially in subjects with hypersensitivity to NSAIDs.
However, no systemic side effects have emerged considering the route of administration and the dosage of the drug administered.

Overdose

No cases of overdose have been reported with the use of this medicine.

Pregnancy and breastfeeding

Ketoprofen lysine salt Zentiva 0.16% spray for oral mucosa should not be used in case of confirmed or suspected pregnancy and during breastfeeding.

Storage

This medicine does not require any particular precautions for storage.

Format

15 ml oral mucosa spray